Literature DB >> 29203356

226th ENMC International Workshop:: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands.

Annemieke Aartsma-Rus1, Alessandra Ferlini2, Elizabeth M McNally3, Pietro Spitali4, H Lee Sweeney5.   

Abstract

Entities:  

Keywords:  Biobank; Biomarker; Duchenne muscular dystrophy; Dystrophin; MRI

Mesh：

Substances：

Year:  2017        PMID： 29203356      PMCID： PMC5957286          DOI： 10.1016/j.nmd.2017.10.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  39 in total

1.  Collaborating to bring new therapies to the patient--the TREAT-NMD model.

Authors:  K Bushby; S Lynn; T Straub
Journal:  Acta Myol       Date:  2009-07

2.  Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy.

Authors:  Luca Bello; Luisa Piva; Andrea Barp; Antonella Taglia; Esther Picillo; Gessica Vasco; Marika Pane; Stefano C Previtali; Yvan Torrente; Elisabetta Gazzerro; Maria Chiara Motta; Gaetano S Grieco; Sara Napolitano; Francesca Magri; Adele D'Amico; Guja Astrea; Sonia Messina; Maria Sframeli; Gian Luca Vita; Patrizia Boffi; Tiziana Mongini; Alessandra Ferlini; Francesca Gualandi; Gianni Soraru'; Mario Ermani; Giuseppe Vita; Roberta Battini; Enrico Bertini; Giacomo P Comi; Angela Berardinelli; Carlo Minetti; Claudio Bruno; Eugenio Mercuri; Luisa Politano; Corrado Angelini; Eric P Hoffman; Elena Pegoraro
Journal:  Neurology       Date:  2012-06-27       Impact factor: 9.910

3.  Duchenne Muscular Dystrophy Myogenic Cells from Urine-Derived Stem Cells Recapitulate the Dystrophin Genotype and Phenotype.

Authors:  Maria Sofia Falzarano; Domenico D'Amario; Andrea Siracusano; Massimo Massetti; Antonio Amodeo; Federica La Neve; Camilla Reina Maroni; Eugenio Mercuri; Hana Osman; Chiara Scotton; Annarita Armaroli; Rachele Rossi; Rita Selvatici; Filippo Crea; Alessandra Ferlini
Journal:  Hum Gene Ther       Date:  2016-10       Impact factor: 5.695

4.  KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

Authors:  Astrid Lièvre; Jean-Baptiste Bachet; Delphine Le Corre; Valérie Boige; Bruno Landi; Jean-François Emile; Jean-François Côté; Gorana Tomasic; Christophe Penna; Michel Ducreux; Philippe Rougier; Frédérique Penault-Llorca; Pierre Laurent-Puig
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

5.  VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid.

Authors:  Erica K M Reeves; Eric P Hoffman; Kanneboyina Nagaraju; Jesse M Damsker; John M McCall
Journal:  Bioorg Med Chem       Date:  2013-02-18       Impact factor: 3.641

6.  EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Authors:  J Guillermo Paez; Pasi A Jänne; Jeffrey C Lee; Sean Tracy; Heidi Greulich; Stacey Gabriel; Paula Herman; Frederic J Kaye; Neal Lindeman; Titus J Boggon; Katsuhiko Naoki; Hidefumi Sasaki; Yoshitaka Fujii; Michael J Eck; William R Sellers; Bruce E Johnson; Matthew Meyerson
Journal:  Science       Date:  2004-04-29       Impact factor: 47.728

Review 7.  Translational and regulatory challenges for exon skipping therapies.

Authors:  Annemieke Aartsma-Rus; Alessandra Ferlini; Nathalie Goemans; Anna M G Pasmooij; Dominic J Wells; Katerine Bushby; Elizabeth Vroom; Pavel Balabanov
Journal:  Hum Gene Ther       Date:  2014-10       Impact factor: 5.695

8.  204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The Netherlands.

Authors:  Alessandra Ferlini; Kevin M Flanigan; Hanns Lochmuller; Francesco Muntoni; Peter A C 't Hoen; Elizabeth McNally
Journal:  Neuromuscul Disord       Date:  2014-09-11       Impact factor: 4.296

9.  miRNAs as serum biomarkers for Duchenne muscular dystrophy.

Authors:  Davide Cacchiarelli; Ivano Legnini; Julie Martone; Valentina Cazzella; Adele D'Amico; Enrico Bertini; Irene Bozzoni
Journal:  EMBO Mol Med       Date:  2011-03-21       Impact factor: 12.137

10.  Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Authors:  Peter C Fong; David S Boss; Timothy A Yap; Andrew Tutt; Peijun Wu; Marja Mergui-Roelvink; Peter Mortimer; Helen Swaisland; Alan Lau; Mark J O'Connor; Alan Ashworth; James Carmichael; Stan B Kaye; Jan H M Schellens; Johann S de Bono
Journal:  N Engl J Med       Date:  2009-06-24       Impact factor: 91.245
View more
  1 in total

Review 1.  Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress.

Authors:  Miranda D Grounds; Jessica R Terrill; Basma A Al-Mshhdani; Marisa N Duong; Hannah G Radley-Crabb; Peter G Arthur
Journal:  Dis Model Mech       Date:  2020-03-02       Impact factor: 5.758
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.